DESTINY-Breast09: 40 Months of PFS Changes Everything

A median progression-free survival over 40 months in the first-line setting stunned the field.

This clip breaks down why DESTINY-Breast09 is being called a practice-changing trial — and why even the control arm outperformed historical expectations.